NGN-401 clinical trials

A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome

This study is looking at a new treatment called NGN-401 for girls and women with Rett Syndrome. It aims to see how well and how safely this gene therapy works to help improve symptoms of the condition.